- Home
- CVAC vs XHR Comparison
CVAC vs XHR Comparison
Compare CVAC & XHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- XHR
- Stock Information
- Founded
- CVAC 2000
- XHR 2007
- Country
- CVAC Germany
- XHR United States
- Employees
- CVAC N/A
- XHR N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- XHR Real Estate Investment Trusts
- Sector
- CVAC Health Care
- XHR Real Estate
- Exchange
- CVAC Nasdaq
- XHR Nasdaq
- Market Cap
- CVAC 1.2B
- XHR 1.3B
- IPO Year
- CVAC 2020
- XHR N/A
- Fundamental
- Price
- CVAC $5.36
- XHR $13.01
- Analyst Decision
- CVAC Hold
- XHR Buy
- Analyst Count
- CVAC 3
- XHR 6
- Target Price
- CVAC $6.83
- XHR $13.83
- AVG Volume (30 Days)
- CVAC 411.0K
- XHR 623.8K
- Earning Date
- CVAC 11-11-2025
- XHR 10-31-2025
- Dividend Yield
- CVAC N/A
- XHR 4.31%
- EPS Growth
- CVAC N/A
- XHR 193.03
- EPS
- CVAC 1.01
- XHR 0.62
- Revenue
- CVAC $599,540,810.00
- XHR $1,075,161,000.00
- Revenue This Year
- CVAC N/A
- XHR $4.71
- Revenue Next Year
- CVAC $23.83
- XHR $2.85
- P/E Ratio
- CVAC $5.34
- XHR $20.98
- Revenue Growth
- CVAC 675.15
- XHR 4.81
- 52 Week Low
- CVAC $2.37
- XHR $8.55
- 52 Week High
- CVAC $5.72
- XHR $16.50
- Technical
- Relative Strength Index (RSI)
- CVAC 45.73
- XHR 42.07
- Support Level
- CVAC $5.34
- XHR $12.75
- Resistance Level
- CVAC $5.41
- XHR $13.13
- Average True Range (ATR)
- CVAC 0.04
- XHR 0.34
- MACD
- CVAC -0.00
- XHR -0.06
- Stochastic Oscillator
- CVAC 18.18
- XHR 35.67
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About XHR Xenia Hotels & Resorts Inc.
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The firm's customer groups include transient business, group business, and contract business.